We haven't seen anything yet , shoestring budget indicates difficult to convince financial support and ongoing delays. Class A shareholders value unable to convert for at least 270 days up to 18 mths if IPO successful. No word on GNBT listing just confirmed dilution. Maybe you have additional info to be optimistic but history has proven to be skeptical. I'm all for positive outlook but we need some reliable signals !!
(1)
(1)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links